ArticleScience advances2021

Exploiting the acquired vulnerability of cisplatin-resistant tumors with a hypoxia-amplifying DNA repair-inhibiting (HYDRI) nanomedicine.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.